Sens. Grassley, Wyden Submit Op-ed on Congressional Action to Lower Drug Prices
October 17, 2019
October 17, 2019
WASHINGTON, Oct. 17 -- Sens. Charles E. Grassley, R-Iowa, and Ron Wyden, D-Oregon, issued the following op-ed on Congressional action to lower drug prices, which was provided to Bloomberg:
It's no secret that health care is a politically divisive issue. In the past decade, national elections have been decided on it, and control of Congress has changed hands in part over it. Despite these differences, there is hope for a bipartisan agreement to lower prescription drug costs.
It's no secret that health care is a politically divisive issue. In the past decade, national elections have been decided on it, and control of Congress has changed hands in part over it. Despite these differences, there is hope for a bipartisan agreement to lower prescription drug costs.